RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial

Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial

Add to Collection
RCTs MJ Jardine, SS Kotwal, A Bassi, C Hockham, M Jones… - bmj, 2022 - bmj.com

Chapter : Section25
Journal Year : 2022
Cited by : 15

… , 778 (99%) participants were randomised from an Indian centre and nine (1%) from an … were older than 60 years (189 (24%)), or had diabetes (197 (25%)). All participants in India …..... Read More

Keywords : ['pragmatic adaptive multicentre phase randomise control trial', 'angiotensin receptor blocker', 'treatment']
PubMed Link : https://www.bmj.com/content/379/bmj-2022-072175
Google Scholar Link : https://scholar.google.com/scholar?cites=2980419111244751662&as_sdt=80005&sciodt=0,11&hl=en&num=20